Neurocrine Biosciences shares owned by PRIMECAP Management Company
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by PRIMECAP Management Company
from 13F filings
Historical chart of PRIMECAP Management Company investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by PRIMECAP Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by PRIMECAP Management Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $72M | 512k | 140.38 |
| 2025-06-30 | $66M | 524k | 125.69 |
| 2025-03-31 | $42M | 382k | 110.60 |
| 2024-12-31 | $54M | 394k | 136.50 |
| 2024-09-30 | $47M | 404k | 115.22 |
| 2024-06-30 | $56M | 409k | 137.67 |
| 2024-03-31 | $55M | 399k | 137.92 |
| 2023-12-31 | $53M | 398k | 131.76 |
| 2023-09-30 | $44M | 392k | 112.50 |
| 2023-06-30 | $37M | 393k | 94.30 |
| 2023-03-31 | $38M | 372k | 101.22 |
| 2022-12-31 | $609k | 5.1k | 119.44 |
More positions owned by PRIMECAP Management Company
View all positions for PRIMECAP Management Company